{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T23:14:33Z","timestamp":1787354073179,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012899","name":"Lanzhou University","doi-asserted-by":"publisher","award":["CY2024-MS-B03"],"award-info":[{"award-number":["CY2024-MS-B03"]}],"id":[{"id":"10.13039\/100012899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012899","name":"Lanzhou University","doi-asserted-by":"publisher","award":["DELC- 202333"],"award-info":[{"award-number":["DELC- 202333"]}],"id":[{"id":"10.13039\/100012899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["23JRRA0962"],"award-info":[{"award-number":["23JRRA0962"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018554","name":"Science and Technology Program of Gansu Province","doi-asserted-by":"publisher","award":["22JR5RA1016"],"award-info":[{"award-number":["22JR5RA1016"]}],"id":[{"id":"10.13039\/501100018554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cellsig.2026.112633","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:27:05Z","timestamp":1780356425000},"page":"112633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["ELK1-YBX1 signaling promotes cisplatin resistance via ferroptosis adaptation in bladder cancer"],"prefix":"10.1016","volume":"146","author":[{"given":"Yao","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieneng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanghuang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panfeng","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10364","key":"10.1016\/j.cellsig.2026.112633_bb0005","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","volume":"400","author":"Comp\u00e9rat","year":"2022","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.cellsig.2026.112633_bb0010","article-title":"Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms","volume":"68","author":"Li","year":"2023","journal-title":"Drug resistance updates\u202f: reviews and commentaries in antimicrobial and anticancer chemotherapy"},{"key":"10.1016\/j.cellsig.2026.112633_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176013","article-title":"Cancer chemotherapy resistance: mechanisms and recent breakthrough in targeted drug delivery","volume":"958","author":"Davodabadi","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112633_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25020717","article-title":"Y-box binding protein 1: Unraveling the multifaceted role in Cancer development and therapeutic potential","volume":"25","author":"Dinh","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112633_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cells11071217","article-title":"YB-1 as an oncoprotein: functions, regulation, post-translational modifications, and targeted therapy","volume":"11","author":"Yin","year":"2022","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112633_bb0030","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/s41418-021-00920-x","article-title":"YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer","volume":"29","author":"Jiang","year":"2022","journal-title":"Cell Death Differ."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112633_bb0035","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s13238-021-00841-y","article-title":"Ferroptosis, radiotherapy, and combination therapeutic strategies","volume":"12","author":"Lei","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.cellsig.2026.112633_bb0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semcancer.2019.03.002","article-title":"Ferroptosis is a type of autophagy-dependent cell death","volume":"66","author":"Zhou","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112633_bb0045","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4143\/crt.2016.572","article-title":"Ferroptosis: a novel anti-tumor action for cisplatin","volume":"50","author":"Guo","year":"2018","journal-title":"Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112633_bb0050","first-page":"399","article-title":"FAM120A deficiency improves resistance to cisplatin in gastric cancer by promoting ferroptosis","volume":"7","author":"Niu","year":"2024","journal-title":"Communicat. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112633_bb0055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41420-025-02712-5","article-title":"SLC25A10 promotes cisplatin resistance by inhibiting ferroptosis in cervical cancer","volume":"11","author":"Ma","year":"2025","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112633_bb0060","first-page":"570","article-title":"KLF11 regulates lung adenocarcinoma ferroptosis and chemosensitivity by suppressing GPX4","volume":"6","author":"Zhao","year":"2023","journal-title":"Communicat. Biol."},{"issue":"Pt B","key":"10.1016\/j.cellsig.2026.112633_bb0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.freeradbiomed.2015.06.014","article-title":"p62 links autophagy and Nrf2 signaling","volume":"88","author":"Jiang","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cellsig.2026.112633_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105575","article-title":"Nrf2 signaling pathway in cisplatin chemotherapy: potential involvement in organ protection and chemoresistance","volume":"167","author":"Mirzaei","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"3\u20134","key":"10.1016\/j.cellsig.2026.112633_bb0075","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10495-023-01817-5","article-title":"m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation","volume":"28","author":"Wang","year":"2023","journal-title":"Apoptosis"},{"issue":"11","key":"10.1016\/j.cellsig.2026.112633_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115938","article-title":"Sulforaphane impact on reactive oxygen species (ROS) in bladder carcinoma","volume":"22","author":"Xie","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2026.112633_bb0085","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.freeradbiomed.2023.09.017","article-title":"CAB39 promotes cisplatin resistance in bladder cancer via the LKB1-AMPK-LC3 pathway","volume":"208","author":"Gao","year":"2023","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112633_bb0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00345-009-0383-3","article-title":"The present and future burden of urinary bladder cancer in the world","volume":"27","author":"Ploeg","year":"2009","journal-title":"World. J. Urol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112633_bb0100","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The different mechanisms of Cancer drug resistance: a brief review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Advanced pharmaceutical bulletin"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112633_bb0105","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112633_bb0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112633_bb0115","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112633_bb0120","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s12935-024-03570-4","article-title":"IMP2 drives chemoresistance by repressing cisplatin-induced apoptosis and ferroptosis via activation of IPO4 and SLC7A11 under hypoxia in bladder cancer","volume":"24","author":"Yan","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112633_bb0125","doi-asserted-by":"crossref","DOI":"10.3892\/or.2022.8453","article-title":"Inhibition of SND1 overcomes chemoresistance in bladder cancer cells by promoting ferroptosis","volume":"49","author":"Zhao","year":"2023","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112633_bb0130","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s11033-025-11016-x","article-title":"The functions and regulation of transcription factor YBX1 in cancers","volume":"52","author":"Qiu","year":"2025","journal-title":"Mol. Biol. Rep."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112633_bb0135","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1080\/15548627.2020.1712108","article-title":"SQSTM1\/p62 activates NFE2L2\/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity","volume":"16","author":"Lee","year":"2020","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112633_bb0140","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/cas.14321","article-title":"p62 promotes bladder cancer cell growth by activating KEAP1\/NRF2-dependent antioxidative response","volume":"111","author":"Li","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cellsig.2026.112633_bb0145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.taap.2018.05.022","article-title":"TRAIL attenuates sulforaphane-mediated Nrf2 and sustains ROS generation, leading to apoptosis of TRAIL-resistant human bladder cancer cells","volume":"352","author":"Jin","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"16","key":"10.1016\/j.cellsig.2026.112633_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/cells14161257","article-title":"Mechanistic insights and clinical implications of ELK1 in solid Tumors: a narrative review","volume":"14","author":"Kalampounias","year":"2025","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112633_bb0155","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s13577-022-00789-z","article-title":"ELK1 suppresses SYTL1 expression by recruiting HDAC2 in bladder cancer progression","volume":"35","author":"Wang","year":"2022","journal-title":"Hum. Cell"},{"key":"10.1016\/j.cellsig.2026.112633_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110840","article-title":"Inhibition of aldo-keto reductase 1C3 overcomes gemcitabine\/cisplatin resistance in bladder cancer","volume":"388","author":"Himura","year":"2024","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112633_bb0165","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2025.13707","article-title":"Multifaceted functions of Y-box binding protein 1 in RNA methylated modifications (review)","volume":"32","author":"Xie","year":"2025","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cellsig.2026.112633_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.112024","article-title":"Gambogic acid induces ferroptosis and suppresses colorectal cancer progression by modulating the m6A modification of p62","volume":"135","author":"Wang","year":"2025","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112633_bb0175","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/s41419-025-08174-y","article-title":"NSUN2 mediated-aberrant 5-methylcytosine methylation regulates autophagy-related ferroptosis in oral squamous cell carcinoma progression","volume":"16","author":"Lu","year":"2025","journal-title":"Cell Death Dis."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682600286X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682600286X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:40:08Z","timestamp":1785876008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089865682600286X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"alternative-id":["S089865682600286X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112633","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ELK1-YBX1 signaling promotes cisplatin resistance via ferroptosis adaptation in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112633"}}